Integer (NYSE:ITGR) announced that it plans to exhibit at the North American Neuromodulation Society (NANS) Annual Meeting this week.

Plano, Texas-based Integer’s showcase takes place at the meeting at Caesars Palace Convention Center in Las Vegas. It spans from Jan. 12 to Jan. 14.

The company, situated at booth #525, intends to offer information about its medical device manufacturing, designs nd development capabilities. These include implantable neuromodulation offerings following the acquisition of Oscor in December 2021, according to a news release.

Integer plans to unveil its latest innovations in neuromodulation. It said these technologies “enable the next-generation of miniaturized active implantable devices.”

Other offerings Integer will display include its new Xcellion Gen-3 fast-charge lithium-ion implantable battery technology. It features best-in-class battery runtime and full recharges in as little as 30 minutes, Integer said.

Michael Sanford, VP of commercialization, called the company “uniquely positioned” with broad expertise. This ranges from batteries to fully integrated implantable pulse generator systems, he said.

“Integer built its leadership position in active implantables by providing OEMs with innovative, development-ready technology solutions that can be customized for each application,” said Sanford. “The objective of our miniaturization effort is to create the next generation of differentiated platform technologies to accelerate and de-risk OEMs’ path to market for novel implantable medical devices.”